nodes	percent_of_prediction	percent_of_DWPC	metapath
Cefdinir—MPO—chronic obstructive pulmonary disease	0.67	1	CbGaD
Cefdinir—SLC22A5—Tiotropium—chronic obstructive pulmonary disease	0.212	1	CbGbCtD
Cefdinir—Bleeding tendency—Montelukast—chronic obstructive pulmonary disease	0.0115	0.101	CcSEcCtD
Cefdinir—Haemorrhagic disorder—Montelukast—chronic obstructive pulmonary disease	0.00378	0.0332	CcSEcCtD
Cefdinir—Erythema nodosum—Montelukast—chronic obstructive pulmonary disease	0.00221	0.0194	CcSEcCtD
Cefdinir—Leukocytoclastic vasculitis—Montelukast—chronic obstructive pulmonary disease	0.00195	0.0171	CcSEcCtD
Cefdinir—Peptic ulcer—Aminophylline—chronic obstructive pulmonary disease	0.00192	0.0168	CcSEcCtD
Cefdinir—Vaginal moniliasis—Salbutamol—chronic obstructive pulmonary disease	0.00183	0.016	CcSEcCtD
Cefdinir—Vulvovaginal candidiasis—Salbutamol—chronic obstructive pulmonary disease	0.00175	0.0154	CcSEcCtD
Cefdinir—Vulvovaginal mycotic infection—Salbutamol—chronic obstructive pulmonary disease	0.00169	0.0148	CcSEcCtD
Cefdinir—Renal failure acute—Roflumilast—chronic obstructive pulmonary disease	0.00151	0.0132	CcSEcCtD
Cefdinir—Rhabdomyolysis—Aminophylline—chronic obstructive pulmonary disease	0.00145	0.0127	CcSEcCtD
Cefdinir—Ileus—Salbutamol—chronic obstructive pulmonary disease	0.0013	0.0114	CcSEcCtD
Cefdinir—Coagulopathy—Salbutamol—chronic obstructive pulmonary disease	0.00118	0.0104	CcSEcCtD
Cefdinir—Candida infection—Tiotropium—chronic obstructive pulmonary disease	0.00115	0.0101	CcSEcCtD
Cefdinir—Pneumonia—Roflumilast—chronic obstructive pulmonary disease	0.00108	0.00948	CcSEcCtD
Cefdinir—Dermatitis exfoliative—Aminophylline—chronic obstructive pulmonary disease	0.000987	0.00864	CcSEcCtD
Cefdinir—Melaena—Arformoterol—chronic obstructive pulmonary disease	0.000953	0.00835	CcSEcCtD
Cefdinir—Melaena—Formoterol—chronic obstructive pulmonary disease	0.000953	0.00835	CcSEcCtD
Cefdinir—Candida infection—Arformoterol—chronic obstructive pulmonary disease	0.000932	0.00816	CcSEcCtD
Cefdinir—Candida infection—Formoterol—chronic obstructive pulmonary disease	0.000932	0.00816	CcSEcCtD
Cefdinir—Hyperkinesia—Montelukast—chronic obstructive pulmonary disease	0.000834	0.0073	CcSEcCtD
Cefdinir—Hyperkinesia—Salbutamol—chronic obstructive pulmonary disease	0.000804	0.00704	CcSEcCtD
Cefdinir—Peptic ulcer—Prednisolone—chronic obstructive pulmonary disease	0.000791	0.00693	CcSEcCtD
Cefdinir—Cefaclor—MPO—chronic obstructive pulmonary disease	0.000709	0.508	CrCbGaD
Cefdinir—Haematuria—Aminophylline—chronic obstructive pulmonary disease	0.000684	0.00599	CcSEcCtD
Cefdinir—Renal failure—Tiotropium—chronic obstructive pulmonary disease	0.000665	0.00583	CcSEcCtD
Cefdinir—Stomatitis—Tiotropium—chronic obstructive pulmonary disease	0.00066	0.00578	CcSEcCtD
Cefdinir—Toxic epidermal necrolysis—Montelukast—chronic obstructive pulmonary disease	0.000625	0.00547	CcSEcCtD
Cefdinir—Aspartate aminotransferase increased—Montelukast—chronic obstructive pulmonary disease	0.000625	0.00547	CcSEcCtD
Cefdinir—Insomnia—Roflumilast—chronic obstructive pulmonary disease	0.000621	0.00544	CcSEcCtD
Cefdinir—Asthma—Arformoterol—chronic obstructive pulmonary disease	0.000612	0.00536	CcSEcCtD
Cefdinir—Asthma—Formoterol—chronic obstructive pulmonary disease	0.000612	0.00536	CcSEcCtD
Cefdinir—Dyspepsia—Roflumilast—chronic obstructive pulmonary disease	0.000604	0.00529	CcSEcCtD
Cefdinir—Asthma—Montelukast—chronic obstructive pulmonary disease	0.0006	0.00525	CcSEcCtD
Cefdinir—Decreased appetite—Roflumilast—chronic obstructive pulmonary disease	0.000597	0.00523	CcSEcCtD
Cefdinir—Gastrointestinal disorder—Roflumilast—chronic obstructive pulmonary disease	0.000592	0.00519	CcSEcCtD
Cefdinir—Constipation—Roflumilast—chronic obstructive pulmonary disease	0.000587	0.00514	CcSEcCtD
Cefdinir—Asthma—Salbutamol—chronic obstructive pulmonary disease	0.000578	0.00507	CcSEcCtD
Cefdinir—Peptic ulcer—Prednisone—chronic obstructive pulmonary disease	0.000575	0.00503	CcSEcCtD
Cefdinir—Gastrointestinal pain—Roflumilast—chronic obstructive pulmonary disease	0.000561	0.00492	CcSEcCtD
Cefdinir—Abdominal pain—Roflumilast—chronic obstructive pulmonary disease	0.000542	0.00475	CcSEcCtD
Cefdinir—Acute coronary syndrome—Arformoterol—chronic obstructive pulmonary disease	0.000538	0.00472	CcSEcCtD
Cefdinir—Acute coronary syndrome—Formoterol—chronic obstructive pulmonary disease	0.000538	0.00472	CcSEcCtD
Cefdinir—Pneumonia—Montelukast—chronic obstructive pulmonary disease	0.000538	0.00471	CcSEcCtD
Cefdinir—Myocardial infarction—Arformoterol—chronic obstructive pulmonary disease	0.000535	0.00469	CcSEcCtD
Cefdinir—Myocardial infarction—Formoterol—chronic obstructive pulmonary disease	0.000535	0.00469	CcSEcCtD
Cefdinir—Conjunctivitis—Formoterol—chronic obstructive pulmonary disease	0.000531	0.00465	CcSEcCtD
Cefdinir—Conjunctivitis—Arformoterol—chronic obstructive pulmonary disease	0.000531	0.00465	CcSEcCtD
Cefdinir—Stevens-Johnson syndrome—Montelukast—chronic obstructive pulmonary disease	0.00053	0.00465	CcSEcCtD
Cefdinir—Jaundice—Montelukast—chronic obstructive pulmonary disease	0.000521	0.00457	CcSEcCtD
Cefdinir—Haematuria—Arformoterol—chronic obstructive pulmonary disease	0.000521	0.00456	CcSEcCtD
Cefdinir—Haematuria—Formoterol—chronic obstructive pulmonary disease	0.000521	0.00456	CcSEcCtD
Cefdinir—Conjunctivitis—Montelukast—chronic obstructive pulmonary disease	0.00052	0.00455	CcSEcCtD
Cefdinir—Agitation—Aminophylline—chronic obstructive pulmonary disease	0.000515	0.00451	CcSEcCtD
Cefdinir—Hypersensitivity—Roflumilast—chronic obstructive pulmonary disease	0.000506	0.00443	CcSEcCtD
Cefdinir—Stomatitis—Salbutamol—chronic obstructive pulmonary disease	0.000503	0.0044	CcSEcCtD
Cefdinir—Jaundice—Salbutamol—chronic obstructive pulmonary disease	0.000503	0.0044	CcSEcCtD
Cefdinir—Conjunctivitis—Salbutamol—chronic obstructive pulmonary disease	0.000501	0.00439	CcSEcCtD
Cefdinir—Asthenia—Roflumilast—chronic obstructive pulmonary disease	0.000492	0.00431	CcSEcCtD
Cefdinir—Haematuria—Salbutamol—chronic obstructive pulmonary disease	0.000492	0.00431	CcSEcCtD
Cefdinir—Convulsion—Aminophylline—chronic obstructive pulmonary disease	0.000486	0.00426	CcSEcCtD
Cefdinir—Diarrhoea—Roflumilast—chronic obstructive pulmonary disease	0.00047	0.00411	CcSEcCtD
Cefdinir—Haemoglobin—Salbutamol—chronic obstructive pulmonary disease	0.000465	0.00408	CcSEcCtD
Cefdinir—Loss of consciousness—Tiotropium—chronic obstructive pulmonary disease	0.000465	0.00407	CcSEcCtD
Cefdinir—Haemorrhage—Salbutamol—chronic obstructive pulmonary disease	0.000463	0.00405	CcSEcCtD
Cefdinir—Anaphylactic shock—Aminophylline—chronic obstructive pulmonary disease	0.000458	0.00401	CcSEcCtD
Cefdinir—Hypertension—Tiotropium—chronic obstructive pulmonary disease	0.000457	0.004	CcSEcCtD
Cefdinir—Erythema multiforme—Montelukast—chronic obstructive pulmonary disease	0.000454	0.00398	CcSEcCtD
Cefdinir—Dizziness—Roflumilast—chronic obstructive pulmonary disease	0.000454	0.00397	CcSEcCtD
Cefdinir—Shock—Aminophylline—chronic obstructive pulmonary disease	0.00045	0.00394	CcSEcCtD
Cefdinir—Chest pain—Tiotropium—chronic obstructive pulmonary disease	0.00045	0.00394	CcSEcCtD
Cefdinir—Dry mouth—Tiotropium—chronic obstructive pulmonary disease	0.00044	0.00386	CcSEcCtD
Cefdinir—Vomiting—Roflumilast—chronic obstructive pulmonary disease	0.000436	0.00382	CcSEcCtD
Cefdinir—Anorexia—Aminophylline—chronic obstructive pulmonary disease	0.000436	0.00382	CcSEcCtD
Cefdinir—Rash—Roflumilast—chronic obstructive pulmonary disease	0.000433	0.00379	CcSEcCtD
Cefdinir—Dermatitis—Roflumilast—chronic obstructive pulmonary disease	0.000432	0.00379	CcSEcCtD
Cefdinir—Headache—Roflumilast—chronic obstructive pulmonary disease	0.00043	0.00377	CcSEcCtD
Cefdinir—Shock—Tiotropium—chronic obstructive pulmonary disease	0.000425	0.00372	CcSEcCtD
Cefdinir—Insomnia—Aminophylline—chronic obstructive pulmonary disease	0.000414	0.00363	CcSEcCtD
Cefdinir—Nausea—Roflumilast—chronic obstructive pulmonary disease	0.000408	0.00357	CcSEcCtD
Cefdinir—Dyspepsia—Aminophylline—chronic obstructive pulmonary disease	0.000403	0.00353	CcSEcCtD
Cefdinir—Decreased appetite—Aminophylline—chronic obstructive pulmonary disease	0.000398	0.00348	CcSEcCtD
Cefdinir—Flatulence—Salbutamol—chronic obstructive pulmonary disease	0.000397	0.00348	CcSEcCtD
Cefdinir—Agitation—Arformoterol—chronic obstructive pulmonary disease	0.000392	0.00344	CcSEcCtD
Cefdinir—Agitation—Formoterol—chronic obstructive pulmonary disease	0.000392	0.00344	CcSEcCtD
Cefdinir—Insomnia—Tiotropium—chronic obstructive pulmonary disease	0.00039	0.00342	CcSEcCtD
Cefdinir—Agitation—Montelukast—chronic obstructive pulmonary disease	0.000384	0.00336	CcSEcCtD
Cefdinir—Dyspepsia—Tiotropium—chronic obstructive pulmonary disease	0.00038	0.00333	CcSEcCtD
Cefdinir—Gastrointestinal pain—Aminophylline—chronic obstructive pulmonary disease	0.000374	0.00328	CcSEcCtD
Cefdinir—Gastrointestinal disorder—Tiotropium—chronic obstructive pulmonary disease	0.000373	0.00326	CcSEcCtD
Cefdinir—Agitation—Salbutamol—chronic obstructive pulmonary disease	0.00037	0.00324	CcSEcCtD
Cefdinir—Constipation—Tiotropium—chronic obstructive pulmonary disease	0.000369	0.00323	CcSEcCtD
Cefdinir—Hypertension—Arformoterol—chronic obstructive pulmonary disease	0.000368	0.00323	CcSEcCtD
Cefdinir—Hypertension—Formoterol—chronic obstructive pulmonary disease	0.000368	0.00323	CcSEcCtD
Cefdinir—Chest pain—Arformoterol—chronic obstructive pulmonary disease	0.000363	0.00318	CcSEcCtD
Cefdinir—Chest pain—Formoterol—chronic obstructive pulmonary disease	0.000363	0.00318	CcSEcCtD
Cefdinir—Convulsion—Montelukast—chronic obstructive pulmonary disease	0.000362	0.00317	CcSEcCtD
Cefdinir—Abdominal pain—Aminophylline—chronic obstructive pulmonary disease	0.000362	0.00317	CcSEcCtD
Cefdinir—Body temperature increased—Aminophylline—chronic obstructive pulmonary disease	0.000362	0.00317	CcSEcCtD
Cefdinir—Dry mouth—Formoterol—chronic obstructive pulmonary disease	0.000355	0.00311	CcSEcCtD
Cefdinir—Dry mouth—Arformoterol—chronic obstructive pulmonary disease	0.000355	0.00311	CcSEcCtD
Cefdinir—Loss of consciousness—Salbutamol—chronic obstructive pulmonary disease	0.000354	0.0031	CcSEcCtD
Cefdinir—Gastrointestinal pain—Tiotropium—chronic obstructive pulmonary disease	0.000353	0.00309	CcSEcCtD
Cefdinir—Anaphylactic shock—Formoterol—chronic obstructive pulmonary disease	0.000348	0.00305	CcSEcCtD
Cefdinir—Anaphylactic shock—Arformoterol—chronic obstructive pulmonary disease	0.000348	0.00305	CcSEcCtD
Cefdinir—Hypertension—Salbutamol—chronic obstructive pulmonary disease	0.000348	0.00305	CcSEcCtD
Cefdinir—Chest pain—Salbutamol—chronic obstructive pulmonary disease	0.000343	0.00301	CcSEcCtD
Cefdinir—Abdominal pain—Tiotropium—chronic obstructive pulmonary disease	0.000341	0.00299	CcSEcCtD
Cefdinir—Anaphylactic shock—Montelukast—chronic obstructive pulmonary disease	0.000341	0.00299	CcSEcCtD
Cefdinir—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.000337	0.00295	CcSEcCtD
Cefdinir—Dry mouth—Salbutamol—chronic obstructive pulmonary disease	0.000335	0.00294	CcSEcCtD
Cefdinir—Hyperkinesia—Prednisone—chronic obstructive pulmonary disease	0.000335	0.00293	CcSEcCtD
Cefdinir—Thrombocytopenia—Montelukast—chronic obstructive pulmonary disease	0.000334	0.00293	CcSEcCtD
Cefdinir—Anaphylactic shock—Salbutamol—chronic obstructive pulmonary disease	0.000329	0.00288	CcSEcCtD
Cefdinir—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.000324	0.00284	CcSEcCtD
Cefdinir—Shock—Salbutamol—chronic obstructive pulmonary disease	0.000324	0.00283	CcSEcCtD
Cefdinir—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.000318	0.00279	CcSEcCtD
Cefdinir—Insomnia—Arformoterol—chronic obstructive pulmonary disease	0.000315	0.00276	CcSEcCtD
Cefdinir—Insomnia—Formoterol—chronic obstructive pulmonary disease	0.000315	0.00276	CcSEcCtD
Cefdinir—Anorexia—Salbutamol—chronic obstructive pulmonary disease	0.000313	0.00275	CcSEcCtD
Cefdinir—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.000313	0.00274	CcSEcCtD
Cefdinir—Somnolence—Arformoterol—chronic obstructive pulmonary disease	0.00031	0.00271	CcSEcCtD
Cefdinir—Somnolence—Formoterol—chronic obstructive pulmonary disease	0.00031	0.00271	CcSEcCtD
Cefdinir—Insomnia—Montelukast—chronic obstructive pulmonary disease	0.000309	0.0027	CcSEcCtD
Cefdinir—Dyspepsia—Formoterol—chronic obstructive pulmonary disease	0.000307	0.00269	CcSEcCtD
Cefdinir—Dyspepsia—Arformoterol—chronic obstructive pulmonary disease	0.000307	0.00269	CcSEcCtD
Cefdinir—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.000305	0.00267	CcSEcCtD
Cefdinir—Somnolence—Montelukast—chronic obstructive pulmonary disease	0.000303	0.00266	CcSEcCtD
Cefdinir—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.000303	0.00265	CcSEcCtD
Cefdinir—Gastrointestinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.000301	0.00263	CcSEcCtD
Cefdinir—Gastrointestinal disorder—Formoterol—chronic obstructive pulmonary disease	0.000301	0.00263	CcSEcCtD
Cefdinir—Dyspepsia—Montelukast—chronic obstructive pulmonary disease	0.0003	0.00263	CcSEcCtD
Cefdinir—Constipation—Arformoterol—chronic obstructive pulmonary disease	0.000298	0.00261	CcSEcCtD
Cefdinir—Constipation—Formoterol—chronic obstructive pulmonary disease	0.000298	0.00261	CcSEcCtD
Cefdinir—Insomnia—Salbutamol—chronic obstructive pulmonary disease	0.000297	0.00261	CcSEcCtD
Cefdinir—Gastrointestinal disorder—Montelukast—chronic obstructive pulmonary disease	0.000295	0.00258	CcSEcCtD
Cefdinir—Somnolence—Salbutamol—chronic obstructive pulmonary disease	0.000292	0.00256	CcSEcCtD
Cefdinir—Acute coronary syndrome—Prednisolone—chronic obstructive pulmonary disease	0.000292	0.00255	CcSEcCtD
Cefdinir—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.000291	0.00255	CcSEcCtD
Cefdinir—Myocardial infarction—Prednisolone—chronic obstructive pulmonary disease	0.00029	0.00254	CcSEcCtD
Cefdinir—Dyspepsia—Salbutamol—chronic obstructive pulmonary disease	0.000289	0.00254	CcSEcCtD
Cefdinir—Purpura—Prednisone—chronic obstructive pulmonary disease	0.000289	0.00253	CcSEcCtD
Cefdinir—Rash—Aminophylline—chronic obstructive pulmonary disease	0.000289	0.00253	CcSEcCtD
Cefdinir—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.000288	0.00253	CcSEcCtD
Cefdinir—Conjunctivitis—Prednisolone—chronic obstructive pulmonary disease	0.000287	0.00252	CcSEcCtD
Cefdinir—Headache—Aminophylline—chronic obstructive pulmonary disease	0.000287	0.00251	CcSEcCtD
Cefdinir—Decreased appetite—Salbutamol—chronic obstructive pulmonary disease	0.000286	0.0025	CcSEcCtD
Cefdinir—Cardiac failure—Prednisone—chronic obstructive pulmonary disease	0.000286	0.0025	CcSEcCtD
Cefdinir—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.000285	0.0025	CcSEcCtD
Cefdinir—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	0.000285	0.00249	CcSEcCtD
Cefdinir—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	0.000285	0.00249	CcSEcCtD
Cefdinir—Gastrointestinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.000284	0.00249	CcSEcCtD
Cefdinir—Constipation—Salbutamol—chronic obstructive pulmonary disease	0.000281	0.00246	CcSEcCtD
Cefdinir—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	0.000279	0.00244	CcSEcCtD
Cefdinir—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	0.000275	0.00241	CcSEcCtD
Cefdinir—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	0.000275	0.00241	CcSEcCtD
Cefdinir—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	0.000275	0.00241	CcSEcCtD
Cefdinir—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	0.000275	0.00241	CcSEcCtD
Cefdinir—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.000274	0.0024	CcSEcCtD
Cefdinir—Rash—Tiotropium—chronic obstructive pulmonary disease	0.000272	0.00238	CcSEcCtD
Cefdinir—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.000272	0.00238	CcSEcCtD
Cefdinir—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.000272	0.00238	CcSEcCtD
Cefdinir—Headache—Tiotropium—chronic obstructive pulmonary disease	0.00027	0.00237	CcSEcCtD
Cefdinir—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	0.00027	0.00236	CcSEcCtD
Cefdinir—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	0.00027	0.00236	CcSEcCtD
Cefdinir—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	0.000269	0.00236	CcSEcCtD
Cefdinir—Haemoglobin—Prednisolone—chronic obstructive pulmonary disease	0.000267	0.00234	CcSEcCtD
Cefdinir—Haemorrhage—Prednisolone—chronic obstructive pulmonary disease	0.000265	0.00233	CcSEcCtD
Cefdinir—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	0.00026	0.00228	CcSEcCtD
Cefdinir—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	0.00026	0.00228	CcSEcCtD
Cefdinir—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.000257	0.00225	CcSEcCtD
Cefdinir—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.000257	0.00225	CcSEcCtD
Cefdinir—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.000256	0.00225	CcSEcCtD
Cefdinir—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.000251	0.0022	CcSEcCtD
Cefdinir—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.00025	0.00219	CcSEcCtD
Cefdinir—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.00025	0.00219	CcSEcCtD
Cefdinir—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.000246	0.00216	CcSEcCtD
Cefdinir—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.000246	0.00216	CcSEcCtD
Cefdinir—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.000245	0.00214	CcSEcCtD
Cefdinir—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	0.000242	0.00212	CcSEcCtD
Cefdinir—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.000241	0.00211	CcSEcCtD
Cefdinir—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.000238	0.00209	CcSEcCtD
Cefdinir—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.000238	0.00209	CcSEcCtD
Cefdinir—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.000236	0.00207	CcSEcCtD
Cefdinir—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.000233	0.00204	CcSEcCtD
Cefdinir—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.000233	0.00204	CcSEcCtD
Cefdinir—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.00023	0.00202	CcSEcCtD
Cefdinir—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.00023	0.00202	CcSEcCtD
Cefdinir—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.000226	0.00198	CcSEcCtD
Cefdinir—Neutropenia—Prednisone—chronic obstructive pulmonary disease	0.000225	0.00197	CcSEcCtD
Cefdinir—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.000225	0.00197	CcSEcCtD
Cefdinir—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.000221	0.00194	CcSEcCtD
Cefdinir—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.000221	0.00194	CcSEcCtD
Cefdinir—Rash—Arformoterol—chronic obstructive pulmonary disease	0.00022	0.00192	CcSEcCtD
Cefdinir—Rash—Formoterol—chronic obstructive pulmonary disease	0.00022	0.00192	CcSEcCtD
Cefdinir—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.000219	0.00192	CcSEcCtD
Cefdinir—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.000219	0.00192	CcSEcCtD
Cefdinir—Headache—Arformoterol—chronic obstructive pulmonary disease	0.000218	0.00191	CcSEcCtD
Cefdinir—Headache—Formoterol—chronic obstructive pulmonary disease	0.000218	0.00191	CcSEcCtD
Cefdinir—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.000217	0.0019	CcSEcCtD
Cefdinir—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.000217	0.0019	CcSEcCtD
Cefdinir—Rash—Montelukast—chronic obstructive pulmonary disease	0.000215	0.00188	CcSEcCtD
Cefdinir—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.000215	0.00188	CcSEcCtD
Cefdinir—Headache—Montelukast—chronic obstructive pulmonary disease	0.000214	0.00187	CcSEcCtD
Cefdinir—Acute coronary syndrome—Prednisone—chronic obstructive pulmonary disease	0.000212	0.00186	CcSEcCtD
Cefdinir—Myocardial infarction—Prednisone—chronic obstructive pulmonary disease	0.000211	0.00185	CcSEcCtD
Cefdinir—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.000209	0.00183	CcSEcCtD
Cefdinir—Rash—Salbutamol—chronic obstructive pulmonary disease	0.000207	0.00182	CcSEcCtD
Cefdinir—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.000207	0.00181	CcSEcCtD
Cefdinir—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.000207	0.00181	CcSEcCtD
Cefdinir—Nausea—Formoterol—chronic obstructive pulmonary disease	0.000207	0.00181	CcSEcCtD
Cefdinir—Headache—Salbutamol—chronic obstructive pulmonary disease	0.000206	0.0018	CcSEcCtD
Cefdinir—Loss of consciousness—Prednisolone—chronic obstructive pulmonary disease	0.000203	0.00178	CcSEcCtD
Cefdinir—Nausea—Montelukast—chronic obstructive pulmonary disease	0.000203	0.00177	CcSEcCtD
Cefdinir—Convulsion—Prednisolone—chronic obstructive pulmonary disease	0.0002	0.00175	CcSEcCtD
Cefdinir—Hypertension—Prednisolone—chronic obstructive pulmonary disease	0.0002	0.00175	CcSEcCtD
Cefdinir—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.000195	0.00171	CcSEcCtD
Cefdinir—Cefazolin—ALB—chronic obstructive pulmonary disease	0.000195	0.139	CrCbGaD
Cefdinir—Haemoglobin—Prednisone—chronic obstructive pulmonary disease	0.000194	0.0017	CcSEcCtD
Cefdinir—Haemorrhage—Prednisone—chronic obstructive pulmonary disease	0.000193	0.00169	CcSEcCtD
Cefdinir—Anaphylactic shock—Prednisolone—chronic obstructive pulmonary disease	0.000189	0.00165	CcSEcCtD
Cefdinir—Shock—Prednisolone—chronic obstructive pulmonary disease	0.000186	0.00163	CcSEcCtD
Cefdinir—Ceftriaxone—ALB—chronic obstructive pulmonary disease	0.000185	0.132	CrCbGaD
Cefdinir—Insomnia—Prednisolone—chronic obstructive pulmonary disease	0.000171	0.00149	CcSEcCtD
Cefdinir—MPO—C-MYB transcription factor network—ELANE—chronic obstructive pulmonary disease	0.000165	0.0992	CbGpPWpGaD
Cefdinir—Cefalotin—ALB—chronic obstructive pulmonary disease	0.000162	0.116	CrCbGaD
Cefdinir—Agitation—Prednisone—chronic obstructive pulmonary disease	0.000154	0.00135	CcSEcCtD
Cefdinir—Loss of consciousness—Prednisone—chronic obstructive pulmonary disease	0.000148	0.00129	CcSEcCtD
Cefdinir—Cephalexin—ALB—chronic obstructive pulmonary disease	0.000147	0.105	CrCbGaD
Cefdinir—Convulsion—Prednisone—chronic obstructive pulmonary disease	0.000146	0.00127	CcSEcCtD
Cefdinir—Hypertension—Prednisone—chronic obstructive pulmonary disease	0.000145	0.00127	CcSEcCtD
Cefdinir—MPO—Vitamin B12 Metabolism—SOD3—chronic obstructive pulmonary disease	0.000141	0.0849	CbGpPWpGaD
Cefdinir—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	0.000139	0.00122	CcSEcCtD
Cefdinir—Anaphylactic shock—Prednisone—chronic obstructive pulmonary disease	0.000137	0.0012	CcSEcCtD
Cefdinir—Shock—Prednisone—chronic obstructive pulmonary disease	0.000135	0.00118	CcSEcCtD
Cefdinir—Anorexia—Prednisone—chronic obstructive pulmonary disease	0.000131	0.00114	CcSEcCtD
Cefdinir—Dizziness—Prednisolone—chronic obstructive pulmonary disease	0.000125	0.00109	CcSEcCtD
Cefdinir—Insomnia—Prednisone—chronic obstructive pulmonary disease	0.000124	0.00109	CcSEcCtD
Cefdinir—Dyspepsia—Prednisone—chronic obstructive pulmonary disease	0.000121	0.00106	CcSEcCtD
Cefdinir—Decreased appetite—Prednisone—chronic obstructive pulmonary disease	0.000119	0.00104	CcSEcCtD
Cefdinir—Rash—Prednisolone—chronic obstructive pulmonary disease	0.000119	0.00104	CcSEcCtD
Cefdinir—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	0.000119	0.00104	CcSEcCtD
Cefdinir—Headache—Prednisolone—chronic obstructive pulmonary disease	0.000118	0.00104	CcSEcCtD
Cefdinir—Constipation—Prednisone—chronic obstructive pulmonary disease	0.000117	0.00103	CcSEcCtD
Cefdinir—MPO—Folate Metabolism—SOD3—chronic obstructive pulmonary disease	0.000115	0.0691	CbGpPWpGaD
Cefdinir—MPO—IL23-mediated signaling events—STAT4—chronic obstructive pulmonary disease	0.000115	0.0689	CbGpPWpGaD
Cefdinir—MPO—IL23-mediated signaling events—IL17A—chronic obstructive pulmonary disease	0.000113	0.0678	CbGpPWpGaD
Cefdinir—Gastrointestinal pain—Prednisone—chronic obstructive pulmonary disease	0.000112	0.000982	CcSEcCtD
Cefdinir—Nausea—Prednisolone—chronic obstructive pulmonary disease	0.000112	0.000981	CcSEcCtD
Cefdinir—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	0.000108	0.000949	CcSEcCtD
Cefdinir—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	0.000108	0.000949	CcSEcCtD
Cefdinir—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	0.000101	0.000885	CcSEcCtD
Cefdinir—Asthenia—Prednisone—chronic obstructive pulmonary disease	9.83e-05	0.000861	CcSEcCtD
Cefdinir—Pruritus—Prednisone—chronic obstructive pulmonary disease	9.7e-05	0.000849	CcSEcCtD
Cefdinir—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	9.38e-05	0.000821	CcSEcCtD
Cefdinir—MPO—Selenium Micronutrient Network—SOD3—chronic obstructive pulmonary disease	9.15e-05	0.0549	CbGpPWpGaD
Cefdinir—Dizziness—Prednisone—chronic obstructive pulmonary disease	9.06e-05	0.000794	CcSEcCtD
Cefdinir—Vomiting—Prednisone—chronic obstructive pulmonary disease	8.71e-05	0.000763	CcSEcCtD
Cefdinir—Rash—Prednisone—chronic obstructive pulmonary disease	8.64e-05	0.000757	CcSEcCtD
Cefdinir—Dermatitis—Prednisone—chronic obstructive pulmonary disease	8.63e-05	0.000756	CcSEcCtD
Cefdinir—Headache—Prednisone—chronic obstructive pulmonary disease	8.59e-05	0.000752	CcSEcCtD
Cefdinir—Nausea—Prednisone—chronic obstructive pulmonary disease	8.14e-05	0.000713	CcSEcCtD
Cefdinir—MPO—IL23-mediated signaling events—NOS2—chronic obstructive pulmonary disease	5.89e-05	0.0354	CbGpPWpGaD
Cefdinir—MPO—Vitamin B12 Metabolism—CRP—chronic obstructive pulmonary disease	5e-05	0.03	CbGpPWpGaD
Cefdinir—MPO—Folate Metabolism—CRP—chronic obstructive pulmonary disease	4.06e-05	0.0244	CbGpPWpGaD
Cefdinir—MPO—IL23-mediated signaling events—IL1B—chronic obstructive pulmonary disease	4.03e-05	0.0242	CbGpPWpGaD
Cefdinir—MPO—C-MYB transcription factor network—GSTM1—chronic obstructive pulmonary disease	3.99e-05	0.0239	CbGpPWpGaD
Cefdinir—MPO—Vitamin B12 Metabolism—SERPINE1—chronic obstructive pulmonary disease	3.84e-05	0.023	CbGpPWpGaD
Cefdinir—MPO—Vitamin B12 Metabolism—ALB—chronic obstructive pulmonary disease	3.83e-05	0.023	CbGpPWpGaD
Cefdinir—SLC15A2—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	3.29e-05	0.0198	CbGpPWpGaD
Cefdinir—MPO—Selenium Micronutrient Network—CRP—chronic obstructive pulmonary disease	3.23e-05	0.0194	CbGpPWpGaD
Cefdinir—MPO—Folate Metabolism—SERPINE1—chronic obstructive pulmonary disease	3.12e-05	0.0187	CbGpPWpGaD
Cefdinir—MPO—Vitamin B12 Metabolism—IL1B—chronic obstructive pulmonary disease	3.12e-05	0.0187	CbGpPWpGaD
Cefdinir—MPO—Folate Metabolism—ALB—chronic obstructive pulmonary disease	3.12e-05	0.0187	CbGpPWpGaD
Cefdinir—SLC15A1—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	3.06e-05	0.0184	CbGpPWpGaD
Cefdinir—SLC22A5—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	3.01e-05	0.018	CbGpPWpGaD
Cefdinir—SLC15A2—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	2.94e-05	0.0176	CbGpPWpGaD
Cefdinir—MPO—IL23-mediated signaling events—TNF—chronic obstructive pulmonary disease	2.92e-05	0.0175	CbGpPWpGaD
Cefdinir—SLC15A1—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	2.72e-05	0.0164	CbGpPWpGaD
Cefdinir—SLC22A5—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	2.68e-05	0.0161	CbGpPWpGaD
Cefdinir—MPO—Folate Metabolism—IL1B—chronic obstructive pulmonary disease	2.54e-05	0.0152	CbGpPWpGaD
Cefdinir—MPO—Selenium Micronutrient Network—SERPINE1—chronic obstructive pulmonary disease	2.48e-05	0.0149	CbGpPWpGaD
Cefdinir—MPO—Selenium Micronutrient Network—ALB—chronic obstructive pulmonary disease	2.47e-05	0.0149	CbGpPWpGaD
Cefdinir—MPO—IL23-mediated signaling events—IL6—chronic obstructive pulmonary disease	2.36e-05	0.0142	CbGpPWpGaD
Cefdinir—MPO—Vitamin B12 Metabolism—TNF—chronic obstructive pulmonary disease	2.26e-05	0.0136	CbGpPWpGaD
Cefdinir—MPO—Selenium Micronutrient Network—IL1B—chronic obstructive pulmonary disease	2.01e-05	0.0121	CbGpPWpGaD
Cefdinir—MPO—Folate Metabolism—TNF—chronic obstructive pulmonary disease	1.84e-05	0.011	CbGpPWpGaD
Cefdinir—MPO—Vitamin B12 Metabolism—IL6—chronic obstructive pulmonary disease	1.82e-05	0.011	CbGpPWpGaD
Cefdinir—MPO—Folate Metabolism—TP53—chronic obstructive pulmonary disease	1.62e-05	0.00974	CbGpPWpGaD
Cefdinir—MPO—Folate Metabolism—IL6—chronic obstructive pulmonary disease	1.48e-05	0.00891	CbGpPWpGaD
Cefdinir—MPO—Selenium Micronutrient Network—TNF—chronic obstructive pulmonary disease	1.46e-05	0.00877	CbGpPWpGaD
Cefdinir—MPO—Selenium Micronutrient Network—IL6—chronic obstructive pulmonary disease	1.18e-05	0.00708	CbGpPWpGaD
Cefdinir—SLC15A2—SLC-mediated transmembrane transport—ALB—chronic obstructive pulmonary disease	7.64e-06	0.00458	CbGpPWpGaD
Cefdinir—SLC15A1—SLC-mediated transmembrane transport—ALB—chronic obstructive pulmonary disease	7.09e-06	0.00425	CbGpPWpGaD
Cefdinir—SLC22A5—SLC-mediated transmembrane transport—ALB—chronic obstructive pulmonary disease	6.97e-06	0.00418	CbGpPWpGaD
Cefdinir—SLC15A2—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	6.46e-06	0.00388	CbGpPWpGaD
Cefdinir—SLC15A1—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	6e-06	0.0036	CbGpPWpGaD
Cefdinir—SLC22A5—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	5.9e-06	0.00354	CbGpPWpGaD
Cefdinir—SLC15A2—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	3.88e-06	0.00233	CbGpPWpGaD
Cefdinir—SLC15A1—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	3.6e-06	0.00216	CbGpPWpGaD
Cefdinir—SLC22A5—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	3.54e-06	0.00213	CbGpPWpGaD
